Literature DB >> 18976247

Factor VII deficiency: clinical manifestation of 717 subjects from Europe and Latin America with mutations in the factor 7 gene.

F H Herrmann1, K Wulff, G Auerswald, S Schulman, J Astermark, A Batorova, W Kreuz, H Pollmann, A Ruiz-Saez, N De Bosch, L Salazar-Sanchez.   

Abstract

The congenital FVII deficiency (FVIID) is a rare haemorrhagic disorder with an autosomal recessive pattern of inheritance. Data on phenotype and the genotype from 717 subjects in Central Europe (six countries), Latin America (Costa Rica, Venezuela) and United States, enrolled in the Greifswald Registry of FVII Deficiency were analysed. We detected 131 different mutations in 73 homozygous, 145 compound heterozygous and 499 heterozygous subjects. Regional differences were observed in the mutation pattern and the clinical profile of the evaluated patients. Seventy-one per cent of homozygous and 50% of compound heterozygous subjects were symptomatic. The clinical manifestations of the homozygous subjects were characterized by intracranial haemorrhage (2%), gastrointestinal bleeding (17%), haemarthrosis (13%), epistaxis (58%), gum bleeding (38%), easy bruising (37%), haematoma (15%), haematuria (10%) and menorrhagia (19 of 26 females, 73%). The clinical variability and genotype-phenotype correlation was evaluated in the homozygous subjects. The pattern of bleeding symptoms among compound heterozygous patients was severe and similar to that of the homozygous patients. The large-scale analysis of 499 heterozygous subjects shows that 93 (19%) presented with spontaneous bleeding symptoms such as haemarthrosis (4%), epistaxis (54%), gum bleeding (14%), easy bruising (38%), haematoma (23%), haematuria (5%) and menorrhagia (19 of 45 females; 42%). The severe haemorrhages - intracranial and gastrointestinal - were not reported in heterozygous subjects. The clinical variability and the regional differences in the mutation pattern are discussed regarding care and treatment.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18976247     DOI: 10.1111/j.1365-2516.2008.01910.x

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


  29 in total

1.  Factor X M402T: a homozygous missense mutation identified as the cause of cross-reacting material-reduced deficiency.

Authors:  Yushi Chikasawa; Keiko Shinozawa; Kagehiro Amano; Kyoichi Ogata; Takeshi Hagiwara; Takashi Suzuki; Hiroshi Inaba; Katsuyuki Fukutake
Journal:  Int J Hematol       Date:  2014-07-27       Impact factor: 2.490

2.  Heterozygous congenital Factor VII deficiency with the 9729del4 mutation, associated with severe spontaneous intracranial bleeding in an adolescent male.

Authors:  Thomas J Cramer; Kristin Anderson; Karanjia Navaz; Justin M Brown; Laurent O Mosnier; Annette von Drygalski
Journal:  Blood Cells Mol Dis       Date:  2015-11-10       Impact factor: 3.039

3.  HEREDITARY FACTOR VII DEFICIENCY IN THE ASIAN ELEPHANT (ELEPHAS MAXIMUS) CAUSED BY A F7 MISSENSE MUTATION.

Authors:  Michael Lynch; Ken McGrath; Karthik Raj; Philippa McLaren; Karen Payne; Richard McCoy; Urs Giger
Journal:  J Wildl Dis       Date:  2017-01-24       Impact factor: 1.535

4.  A novel missense mutation in the FGB g. 3354 T>A (p. Y41N), fibrinogen Caracas VIII.

Authors:  Rita Marchi; Héctor Rojas; Michael Meyer; Oscar Castillo; Arlette De Sáez Ruiz; John W Weisel
Journal:  Thromb Haemost       Date:  2011-02-08       Impact factor: 5.249

Review 5.  Treatment of rare factor deficiencies in 2016.

Authors:  Flora Peyvandi; Marzia Menegatti
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

6.  Surgery in patients with congenital factor VII deficiency: A single center experience.

Authors:  Shin-Hee Kim; Young Shil Park; Kee-Hwan Kwon; Jae Hoon Lee; Kwang Chul Kim; Myung Chul Yoo
Journal:  Korean J Hematol       Date:  2012-12-24

7.  Recurrent Bleedings in Newborn: A Factor VII Deficiency Case Report.

Authors:  Kim Cattivelli; Cristina Distefano; Lorenza Bonetti; Sophie Testa; Simona Maria Siboni; Alessandro Plebani; Carlo Poggiani
Journal:  Transfus Med Hemother       Date:  2018-03-08       Impact factor: 3.747

Review 8.  Rare congenital bleeding disorders.

Authors:  Massimo Franchini; Giuseppe Marano; Simonetta Pupella; Stefania Vaglio; Francesca Masiello; Eva Veropalumbo; Vanessa Piccinini; Ilaria Pati; Liviana Catalano; Giancarlo Maria Liumbruno
Journal:  Ann Transl Med       Date:  2018-09

9.  Rare and low-frequency variants and their association with plasma levels of fibrinogen, FVII, FVIII, and vWF.

Authors:  Jennifer E Huffman; Paul S de Vries; Alanna C Morrison; Maria Sabater-Lleal; Tim Kacprowski; Paul L Auer; Jennifer A Brody; Daniel I Chasman; Ming-Huei Chen; Xiuqing Guo; Li-An Lin; Riccardo E Marioni; Martina Müller-Nurasyid; Lisa R Yanek; Nathan Pankratz; Megan L Grove; Moniek P M de Maat; Mary Cushman; Kerri L Wiggins; Lihong Qi; Bengt Sennblad; Sarah E Harris; Ozren Polasek; Helene Riess; Fernando Rivadeneira; Lynda M Rose; Anuj Goel; Kent D Taylor; Alexander Teumer; André G Uitterlinden; Dhananjay Vaidya; Jie Yao; Weihong Tang; Daniel Levy; Melanie Waldenberger; Diane M Becker; Aaron R Folsom; Franco Giulianini; Andreas Greinacher; Albert Hofman; Chiang-Ching Huang; Charles Kooperberg; Angela Silveira; John M Starr; Konstantin Strauch; Rona J Strawbridge; Alan F Wright; Barbara McKnight; Oscar H Franco; Neil Zakai; Rasika A Mathias; Bruce M Psaty; Paul M Ridker; Geoffrey H Tofler; Uwe Völker; Hugh Watkins; Myriam Fornage; Anders Hamsten; Ian J Deary; Eric Boerwinkle; Wolfgang Koenig; Jerome I Rotter; Caroline Hayward; Abbas Dehghan; Alex P Reiner; Christopher J O'Donnell; Nicholas L Smith
Journal:  Blood       Date:  2015-06-23       Impact factor: 22.113

10.  Identification of genetic defects underlying FVII deficiency in 10 patients belonging to eight unrelated families of the North provinces from Tunisia.

Authors:  Hejer Elmahmoudi; Fatma Ben-Lakhal; Wijden Elborji; Asma Jlizi; Kaouther Zahra; Rim Sassi; Moez Zorgan; Balkis Meddeb; Amel Elgaaied Ben Ammar; Emna Gouider
Journal:  Diagn Pathol       Date:  2012-08-08       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.